Colchicine to Reduce Coronary Artery Inflammation in People With HIV

NCT07704164 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection
Cardiovascular Diseases (CVD)

Interventions

DRUG: Colchicine 0.5 mg
DRUG: Placebo

Sponsor

Instituto de Investigación Hospital Universitario La Paz

Collaborators

[object Object]